Cronos Group (TSE:CRON) Shares Up 4.6% – Time to Buy?

Cronos Group Inc. (TSE:CRON)’s stock price traded up 4.6% during trading on Monday . The company traded as high as C$4.52 and last traded at C$4.52. Approximately 111,264 shares changed hands during mid-day trading, a decline of 34% from the average daily volume of 169,367 shares. The stock had previously closed at C$4.32.

Analysts Set New Price Targets

Separately, TD raised their price target on Cronos Group from C$5.50 to C$6.00 and gave the company a “buy” rating in a research report on Monday, August 10th. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of C$4.92.

Cronos Group Stock Performance

The firm has a market capitalization of C$1.72 billion, a P/E ratio of 24.63, a price-to-earnings-growth ratio of 0.12 and a beta of 1.30. The company has a debt-to-equity ratio of 0.12, a quick ratio of 24.01 and a current ratio of 16.18. The stock has a 50-day moving average of C$4.26 and a 200 day moving average of C$3.88.

About Cronos Group

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S.